Trial
NCT02743806
Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Takeda
Collaborators
—
Condition
Colitis, Ulcerative
Intervention
Vedolizumab
Why stopped
Early Completed - Alternative Source of Drug Available
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-18